You are here » Home » Markets » Stocks » Announcements

ANNOUNCEMENTS

Announcement for "Aurobindo Pharma Ltd"

Aurobindo Pharma Ltd Updates

  • 20/03/2017
  • |
  • bse

Aurobindo Pharma Ltd Allotted 697823 Equity Shares Of Re.1/- Each Under ESOP Scheme Of The Company

  • 10/03/2017
  • |
  • bse

Aurobindo Pharma Ltd Allotment of Shares under ESOP

  • 09/03/2017
  • |
  • bse

Aurobindo Pharma Ltd Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011

  • 06/03/2017
  • |
  • bse

Aurobindo Pharma Ltd Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011

  • 06/03/2017
  • |
  • bse

Aurobindo Pharma Ltd Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011

  • 28/02/2017
  • |
  • bse

Aurobindo Pharma Ltd Transcript of earnings call

  • 23/02/2017
  • |
  • bse

Aurobindo Pharma Ltd Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011

  • 23/02/2017
  • |
  • bse

Aurobindo Pharma Ltd Presentation to the Investors / Analysts

  • 22/02/2017
  • |
  • bse

Aurobindo Pharma Ltd Investor Presentation for December 31 2016

  • 13/02/2017
  • |
  • bse

Aurobindo Pharma Ltd Investor Presentation for December 31 2016

  • 09/02/2017
  • |
  • bse

Aurobindo Pharma Ltd Aurobindo Pharma Forays into Biosimilars Development through an acquisition of Four Products from TL

  • 09/02/2017
  • |
  • bse

Aurobindo Pharma Ltd Change in Board of Directors

  • 09/02/2017
  • |
  • bse

Aurobindo Pharma Ltd Results Press Release for December 31 2016

  • 09/02/2017
  • |
  • bse

Aurobindo Pharma Ltd Announces Q3 results (Standalone & Consolidated) & Limited Review Report (Standalone & Consolidated)

  • 09/02/2017
  • |
  • bse

Aurobindo Pharma Ltd Analyst / Investor Call

  • 06/02/2017
  • |
  • bse

Aurobindo Pharma Ltd Q3 results on Feb 09 2017

  • 25/01/2017
  • |
  • bse

Aurobindo Pharma Ltd Closure of Trading Window

  • 24/01/2017
  • |
  • bse

Aurobindo Pharma Ltd Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011

  • 19/01/2017
  • |
  • bse

Aurobindo Pharma Ltd Disclosures under Reg. 10(6) of SEBI (SAST) Regulations 2011

  • 19/01/2017
  • |
  • bse